I completed my medical school at the University of Basel in 2018 and subsequently started my specialisation in psychiatry and psychotherapy. During my two years working as a resident, I gained my first clinical experience working at a crisis intervention center and a unit focusing in the treatment of affective, anxiety and psychosomatic disorders. My conceptual interest in the field of psychedelics as a novel therapeutical approach in mental health grew during my clinical work with patients. I am particularly fascinated by the psychological components of substance-induced mind-altering states and their psychotherapeutical potentials. After two years as a clinician, I started my MD-PhD in the psychopharmacological research team of Prof. Matthias E. Liechti at the University Hospital of Basel where I conduct two PhD projects investigating the oral bioequivalence and bioavailability of oral formulations of LSD and in a second study investigating 2C-B's acute subjective effects and pharmacology.